0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
OTC Painkiller - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-24P5859
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global OTC Painkiller Market Size Status and Forecast 2021 2027
BUY CHAPTERS

OTC Painkiller - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24P5859
Report
October 2024
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Painkiller - Market Size

The global market for OTC Painkiller was estimated to be worth US$ 21040 million in 2023 and is forecast to a readjusted size of US$ 27850 million by 2030 with a CAGR of 4.1% during the forecast period 2024-2030

OTC Painkiller - Market

OTC Painkiller - Market

There are two main types of OTC pain medicines: acetaminophen (Tylenol) and nonsteroidal anti-inflammatory drugs (NSAIDs). Aspirin, naproxen (Aleve), and ibuprofen (Advil, Motrin) are examples of OTC NSAIDs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Painkiller, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of OTC Painkiller by region & country, by Type, and by Application.
The OTC Painkiller market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Painkiller.
Market Segmentation

Scope of OTC Painkiller - Market Report

Report Metric Details
Report Name OTC Painkiller - Market
Forecasted market size in 2030 US$ 27850 million
CAGR 4.1%
Forecasted years 2024 - 2030
Segment by Type:
  • Acetaminophen
  • NSAIDs
Segment by Application
  • Hospitals
  • Drugstores
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of OTC Painkiller manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of OTC Painkiller in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of OTC Painkiller in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the OTC Painkiller - Market size in 2030?

Ans: The OTC Painkiller - Market size in 2030 will be US$ 27850 million.

Who are the main players in the OTC Painkiller - Market report?

Ans: The main players in the OTC Painkiller - Market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan

What are the Application segmentation covered in the OTC Painkiller - Market report?

Ans: The Applications covered in the OTC Painkiller - Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the OTC Painkiller - Market report?

Ans: The Types covered in the OTC Painkiller - Market report are Acetaminophen, NSAIDs

1 Market Overview
1.1 OTC Painkiller Product Introduction
1.2 Global OTC Painkiller Market Size Forecast
1.3 OTC Painkiller Market Trends & Drivers
1.3.1 OTC Painkiller Industry Trends
1.3.2 OTC Painkiller Market Drivers & Opportunity
1.3.3 OTC Painkiller Market Challenges
1.3.4 OTC Painkiller Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OTC Painkiller Players Revenue Ranking (2023)
2.2 Global OTC Painkiller Revenue by Company (2019-2024)
2.3 Key Companies OTC Painkiller Manufacturing Base Distribution and Headquarters
2.4 Key Companies OTC Painkiller Product Offered
2.5 Key Companies Time to Begin Mass Production of OTC Painkiller
2.6 OTC Painkiller Market Competitive Analysis
2.6.1 OTC Painkiller Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by OTC Painkiller Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Painkiller as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Acetaminophen
3.1.2 NSAIDs
3.2 Global OTC Painkiller Sales Value by Type
3.2.1 Global OTC Painkiller Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global OTC Painkiller Sales Value, by Type (2019-2030)
3.2.3 Global OTC Painkiller Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Drugstores
4.1.3 Others
4.2 Global OTC Painkiller Sales Value by Application
4.2.1 Global OTC Painkiller Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global OTC Painkiller Sales Value, by Application (2019-2030)
4.2.3 Global OTC Painkiller Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global OTC Painkiller Sales Value by Region
5.1.1 Global OTC Painkiller Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global OTC Painkiller Sales Value by Region (2019-2024)
5.1.3 Global OTC Painkiller Sales Value by Region (2025-2030)
5.1.4 Global OTC Painkiller Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America OTC Painkiller Sales Value, 2019-2030
5.2.2 North America OTC Painkiller Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe OTC Painkiller Sales Value, 2019-2030
5.3.2 Europe OTC Painkiller Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific OTC Painkiller Sales Value, 2019-2030
5.4.2 Asia Pacific OTC Painkiller Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America OTC Painkiller Sales Value, 2019-2030
5.5.2 South America OTC Painkiller Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa OTC Painkiller Sales Value, 2019-2030
5.6.2 Middle East & Africa OTC Painkiller Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OTC Painkiller Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions OTC Painkiller Sales Value
6.3 United States
6.3.1 United States OTC Painkiller Sales Value, 2019-2030
6.3.2 United States OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.3.3 United States OTC Painkiller Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe OTC Painkiller Sales Value, 2019-2030
6.4.2 Europe OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe OTC Painkiller Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China OTC Painkiller Sales Value, 2019-2030
6.5.2 China OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.5.3 China OTC Painkiller Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan OTC Painkiller Sales Value, 2019-2030
6.6.2 Japan OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan OTC Painkiller Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea OTC Painkiller Sales Value, 2019-2030
6.7.2 South Korea OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea OTC Painkiller Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia OTC Painkiller Sales Value, 2019-2030
6.8.2 Southeast Asia OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia OTC Painkiller Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India OTC Painkiller Sales Value, 2019-2030
6.9.2 India OTC Painkiller Sales Value by Type (%), 2023 VS 2030
6.9.3 India OTC Painkiller Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Profile
7.1.2 Pfizer Main Business
7.1.3 Pfizer OTC Painkiller Products, Services and Solutions
7.1.4 Pfizer OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.1.5 Pfizer Recent Developments
7.2 GSK
7.2.1 GSK Profile
7.2.2 GSK Main Business
7.2.3 GSK OTC Painkiller Products, Services and Solutions
7.2.4 GSK OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.2.5 GSK Recent Developments
7.3 Grunenthal
7.3.1 Grunenthal Profile
7.3.2 Grunenthal Main Business
7.3.3 Grunenthal OTC Painkiller Products, Services and Solutions
7.3.4 Grunenthal OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.3.5 Bayer Recent Developments
7.4 Bayer
7.4.1 Bayer Profile
7.4.2 Bayer Main Business
7.4.3 Bayer OTC Painkiller Products, Services and Solutions
7.4.4 Bayer OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.4.5 Bayer Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi OTC Painkiller Products, Services and Solutions
7.5.4 Sanofi OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Profile
7.6.2 Eli Lilly Main Business
7.6.3 Eli Lilly OTC Painkiller Products, Services and Solutions
7.6.4 Eli Lilly OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.6.5 Eli Lilly Recent Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Profile
7.7.2 AstraZeneca Main Business
7.7.3 AstraZeneca OTC Painkiller Products, Services and Solutions
7.7.4 AstraZeneca OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.7.5 AstraZeneca Recent Developments
7.8 Endo
7.8.1 Endo Profile
7.8.2 Endo Main Business
7.8.3 Endo OTC Painkiller Products, Services and Solutions
7.8.4 Endo OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.8.5 Endo Recent Developments
7.9 Merck
7.9.1 Merck Profile
7.9.2 Merck Main Business
7.9.3 Merck OTC Painkiller Products, Services and Solutions
7.9.4 Merck OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.9.5 Merck Recent Developments
7.10 Depomed
7.10.1 Depomed Profile
7.10.2 Depomed Main Business
7.10.3 Depomed OTC Painkiller Products, Services and Solutions
7.10.4 Depomed OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.10.5 Depomed Recent Developments
7.11 Yunnan Baiyao
7.11.1 Yunnan Baiyao Profile
7.11.2 Yunnan Baiyao Main Business
7.11.3 Yunnan Baiyao OTC Painkiller Products, Services and Solutions
7.11.4 Yunnan Baiyao OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.11.5 Yunnan Baiyao Recent Developments
7.12 Teva
7.12.1 Teva Profile
7.12.2 Teva Main Business
7.12.3 Teva OTC Painkiller Products, Services and Solutions
7.12.4 Teva OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.12.5 Teva Recent Developments
7.13 J&J
7.13.1 J&J Profile
7.13.2 J&J Main Business
7.13.3 J&J OTC Painkiller Products, Services and Solutions
7.13.4 J&J OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.13.5 J&J Recent Developments
7.14 Allergan
7.14.1 Allergan Profile
7.14.2 Allergan Main Business
7.14.3 Allergan OTC Painkiller Products, Services and Solutions
7.14.4 Allergan OTC Painkiller Revenue (US$ Million) & (2019-2024)
7.14.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 OTC Painkiller Industrial Chain
8.2 OTC Painkiller Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 OTC Painkiller Sales Model
8.5.2 Sales Channel
8.5.3 OTC Painkiller Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. OTC Painkiller Market Trends
    Table 2. OTC Painkiller Market Drivers & Opportunity
    Table 3. OTC Painkiller Market Challenges
    Table 4. OTC Painkiller Market Restraints
    Table 5. Global OTC Painkiller Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global OTC Painkiller Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies OTC Painkiller Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies OTC Painkiller Product Type
    Table 9. Key Companies Time to Begin Mass Production of OTC Painkiller
    Table 10. Global OTC Painkiller Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Painkiller as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global OTC Painkiller Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global OTC Painkiller Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global OTC Painkiller Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global OTC Painkiller Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global OTC Painkiller Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global OTC Painkiller Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global OTC Painkiller Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global OTC Painkiller Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global OTC Painkiller Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global OTC Painkiller Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global OTC Painkiller Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global OTC Painkiller Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global OTC Painkiller Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global OTC Painkiller Sales Value by Region (2019-2024) & (%)
    Table 27. Global OTC Painkiller Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions OTC Painkiller Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions OTC Painkiller Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions OTC Painkiller Sales Value, (2025-2030) & (US$ Million)
    Table 31. Pfizer Basic Information List
    Table 32. Pfizer Description and Business Overview
    Table 33. Pfizer OTC Painkiller Products, Services and Solutions
    Table 34. Revenue (US$ Million) in OTC Painkiller Business of Pfizer (2019-2024)
    Table 35. Pfizer Recent Developments
    Table 36. GSK Basic Information List
    Table 37. GSK Description and Business Overview
    Table 38. GSK OTC Painkiller Products, Services and Solutions
    Table 39. Revenue (US$ Million) in OTC Painkiller Business of GSK (2019-2024)
    Table 40. GSK Recent Developments
    Table 41. Grunenthal Basic Information List
    Table 42. Grunenthal Description and Business Overview
    Table 43. Grunenthal OTC Painkiller Products, Services and Solutions
    Table 44. Revenue (US$ Million) in OTC Painkiller Business of Grunenthal (2019-2024)
    Table 45. Grunenthal Recent Developments
    Table 46. Bayer Basic Information List
    Table 47. Bayer Description and Business Overview
    Table 48. Bayer OTC Painkiller Products, Services and Solutions
    Table 49. Revenue (US$ Million) in OTC Painkiller Business of Bayer (2019-2024)
    Table 50. Bayer Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi OTC Painkiller Products, Services and Solutions
    Table 54. Revenue (US$ Million) in OTC Painkiller Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Eli Lilly Basic Information List
    Table 57. Eli Lilly Description and Business Overview
    Table 58. Eli Lilly OTC Painkiller Products, Services and Solutions
    Table 59. Revenue (US$ Million) in OTC Painkiller Business of Eli Lilly (2019-2024)
    Table 60. Eli Lilly Recent Developments
    Table 61. AstraZeneca Basic Information List
    Table 62. AstraZeneca Description and Business Overview
    Table 63. AstraZeneca OTC Painkiller Products, Services and Solutions
    Table 64. Revenue (US$ Million) in OTC Painkiller Business of AstraZeneca (2019-2024)
    Table 65. AstraZeneca Recent Developments
    Table 66. Endo Basic Information List
    Table 67. Endo Description and Business Overview
    Table 68. Endo OTC Painkiller Products, Services and Solutions
    Table 69. Revenue (US$ Million) in OTC Painkiller Business of Endo (2019-2024)
    Table 70. Endo Recent Developments
    Table 71. Merck Basic Information List
    Table 72. Merck Description and Business Overview
    Table 73. Merck OTC Painkiller Products, Services and Solutions
    Table 74. Revenue (US$ Million) in OTC Painkiller Business of Merck (2019-2024)
    Table 75. Merck Recent Developments
    Table 76. Depomed Basic Information List
    Table 77. Depomed Description and Business Overview
    Table 78. Depomed OTC Painkiller Products, Services and Solutions
    Table 79. Revenue (US$ Million) in OTC Painkiller Business of Depomed (2019-2024)
    Table 80. Depomed Recent Developments
    Table 81. Yunnan Baiyao Basic Information List
    Table 82. Yunnan Baiyao Description and Business Overview
    Table 83. Yunnan Baiyao OTC Painkiller Products, Services and Solutions
    Table 84. Revenue (US$ Million) in OTC Painkiller Business of Yunnan Baiyao (2019-2024)
    Table 85. Yunnan Baiyao Recent Developments
    Table 86. Teva Basic Information List
    Table 87. Teva Description and Business Overview
    Table 88. Teva OTC Painkiller Products, Services and Solutions
    Table 89. Revenue (US$ Million) in OTC Painkiller Business of Teva (2019-2024)
    Table 90. Teva Recent Developments
    Table 91. J&J Basic Information List
    Table 92. J&J Description and Business Overview
    Table 93. J&J OTC Painkiller Products, Services and Solutions
    Table 94. Revenue (US$ Million) in OTC Painkiller Business of J&J (2019-2024)
    Table 95. J&J Recent Developments
    Table 96. Allergan Basic Information List
    Table 97. Allergan Description and Business Overview
    Table 98. Allergan OTC Painkiller Products, Services and Solutions
    Table 99. Revenue (US$ Million) in OTC Painkiller Business of Allergan (2019-2024)
    Table 100. Allergan Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. OTC Painkiller Downstream Customers
    Table 104. OTC Painkiller Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. OTC Painkiller Product Picture
    Figure 2. Global OTC Painkiller Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 4. OTC Painkiller Report Years Considered
    Figure 5. Global OTC Painkiller Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Painkiller Revenue in 2023
    Figure 7. OTC Painkiller Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Acetaminophen Picture
    Figure 9. NSAIDs Picture
    Figure 10. Global OTC Painkiller Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global OTC Painkiller Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Drugstores
    Figure 14. Product Picture of Others
    Figure 15. Global OTC Painkiller Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global OTC Painkiller Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America OTC Painkiller Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe OTC Painkiller Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific OTC Painkiller Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America OTC Painkiller Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa OTC Painkiller Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa OTC Painkiller Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions OTC Painkiller Sales Value (%), (2019-2030)
    Figure 28. United States OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 34. China OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 36. China OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 46. India OTC Painkiller Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India OTC Painkiller Sales Value by Type (%), 2023 VS 2030
    Figure 48. India OTC Painkiller Sales Value by Application (%), 2023 VS 2030
    Figure 49. OTC Painkiller Industrial Chain
    Figure 50. OTC Painkiller Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-9U15196
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-14K1494
Thu Dec 12 00:00:00 UTC 2024

Add to Cart